2 Classes Certified In Drug Pricing Suit
By Erin Marie Daly · September 30, 2008, 12:00 AM EDT
In a blow to AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Co., a federal judge has given the green light to two national classes in the multidistrict litigation over average wholesale drug...
To view the full article, register now.